These healthcare stocks can give investors a good mix of dividends and growth.
News & Analysis: Abbott Laboratories
This device, which is still in development, could help hundreds of thousands of Americans if approved.
The healthcare stock has produced returns of more than 90% in five years and it's still going strong.
Engineers can better test new prosthetic heart valves and cardiac devices without needing live subjects.
Both medical device stocks have characteristics investors should consider.
This system now has approval to target all areas of the brain associated with movement disorders.
The recently launched system has helped the medical device company's struggling neurology business.
ABT earnings call for the period ending December 31, 2019.
The Dividend Aristocrat also gave strong guidance for 2020.
The healthcare giant delivered a solid quarterly performance yet again, with sales growth in all of its segments.